These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35801591)

  • 1. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
    Crouchet E; Li S; Sojoodi M; Bandiera S; Fujiwara N; El Saghire H; Zhu S; Qian T; Rasha FA; Del Zompo F; Barrett SC; Schaeffer E; Oudot MA; Ponsolles C; Durand SC; Ghoshal S; Arora G; Giannone F; Chung RT; Slovic N; Van Renne N; Felli E; Pessaux P; Lupberger J; Pochet N; Schuster C; Tanabe KK; Hoshida Y; Fuchs BC; Baumert TF
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35801591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
    Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
    Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
    Yoshiji H; Kuriyama S; Fukui H
    Tumour Biol; 2002; 23(6):348-56. PubMed ID: 12677092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.
    Ho CM; Lee CH; Lee MC; Zhang JF; Wang JY; Hu RH; Lee PH
    BMC Cancer; 2018 Apr; 18(1):401. PubMed ID: 29631561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
    Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
    J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
    Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
    Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.
    Li S; Ghoshal S; Sojoodi M; Arora G; Masia R; Erstad DJ; Lanuti M; Hoshida Y; Baumert TF; Tanabe KK; Fuchs BC
    J Gastrointest Surg; 2019 Jan; 23(1):101-111. PubMed ID: 30367397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Nasr M; Selima E; Hamed O; Kazem A
    Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renin-angiotensin system in hepatocellular carcinoma.
    Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Fukui H
    Curr Cancer Drug Targets; 2011 May; 11(4):431-41. PubMed ID: 21395547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma.
    Jühling F; Hamdane N; Crouchet E; Li S; El Saghire H; Mukherji A; Fujiwara N; Oudot MA; Thumann C; Saviano A; Roca Suarez AA; Goto K; Masia R; Sojoodi M; Arora G; Aikata H; Ono A; Tabrizian P; Schwartz M; Polyak SJ; Davidson I; Schmidl C; Bock C; Schuster C; Chayama K; Pessaux P; Tanabe KK; Hoshida Y; Zeisel MB; Duong FH; Fuchs BC; Baumert TF
    Gut; 2021 Jan; 70(1):157-169. PubMed ID: 32217639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.
    Barone M; Viggiani MT; Losurdo G; Principi M; Leo AD
    World J Gastroenterol; 2019 May; 25(20):2524-2538. PubMed ID: 31171895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
    DePeralta DK; Wei L; Ghoshal S; Schmidt B; Lauwers GY; Lanuti M; Chung RT; Tanabe KK; Fuchs BC
    Cancer; 2016 Apr; 122(8):1216-27. PubMed ID: 26914713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.
    Jonsson JR; Clouston AD; Ando Y; Kelemen LI; Horn MJ; Adamson MD; Purdie DM; Powell EE
    Gastroenterology; 2001 Jul; 121(1):148-55. PubMed ID: 11438504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
    Crouchet E; Bandiera S; Fujiwara N; Li S; El Saghire H; Fernández-Vaquero M; Riedl T; Sun X; Hirschfield H; Jühling F; Zhu S; Roehlen N; Ponsolles C; Heydmann L; Saviano A; Qian T; Venkatesh A; Lupberger J; Verrier ER; Sojoodi M; Oudot MA; Duong FHT; Masia R; Wei L; Thumann C; Durand SC; González-Motos V; Heide D; Hetzer J; Nakagawa S; Ono A; Song WM; Higashi T; Sanchez R; Kim RS; Bian CB; Kiani K; Croonenborghs T; Subramanian A; Chung RT; Straub BK; Schuppan D; Ankavay M; Cocquerel L; Schaeffer E; Goossens N; Koh AP; Mahajan M; Nair VD; Gunasekaran G; Schwartz ME; Bardeesy N; Shalek AK; Rozenblatt-Rosen O; Regev A; Felli E; Pessaux P; Tanabe KK; Heikenwälder M; Schuster C; Pochet N; Zeisel MB; Fuchs BC; Hoshida Y; Baumert TF
    Nat Commun; 2021 Sep; 12(1):5525. PubMed ID: 34535664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
    Luther DJ; Ohanyan V; Shamhart PE; Hodnichak CM; Sisakian H; Booth TD; Meszaros JG; Bishayee A
    Invest New Drugs; 2011 Apr; 29(2):380-91. PubMed ID: 19812893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y
    Oncol Rep; 2005 Mar; 13(3):491-5. PubMed ID: 15706423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Pinyopornpanish K; Al-Yaman W; Butler RS; Carey W; McCullough A; Romero-Marrero C
    Am J Gastroenterol; 2021 Nov; 116(11):2258-2269. PubMed ID: 34212895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.